Effect of solvents quality on determination of particle size and polydispersity of nanoparticles

被引:5
作者
Motwani, S. K. [1 ]
Khar, R. K. [1 ]
Ahmad, F. J. [1 ]
Chopra, S. [1 ]
机构
[1] Fac Pharm, Dept Pharmaceut, New Delhi, India
关键词
quality of solvents; chitosan; nanoparticles; particle size; polydispersity; formulation;
D O I
10.1080/17458080600960002
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanotechnology is of great interest to researchers and industrialists and nanocolloidal carrier systems for drug delivery have been studied in great detail, but while much research has been carried out on the preparation of nanoparticles using a variety of techniques employing various solvents, no attention has been given to the quality of solvents used in the process of nanoparticles characterization. The present investigation aimed to study the effect of solvents quality on the chitosan nanoparticles characterization for average particle size (Z) and polydispersity index (P. I.). Particle size distribution study showed that the number of particles contributed by solvents significantly affects both the Z and P. I. of the nanoparticulate suspensions leading to ambiguous results. While the Z decreases upon dilution with organic solvents, the phosphate buffer and water causes a net increase in Z because of the introduction of larger extraneous nanoparticles. The P. I. was found to increase with dilution because of the differences in the size of the polymeric nanoparticles and the nanoparticles introduced by the solvent upon dilution. The study thus recommends use of the highest quality of solvents in nanoparticles manufacturing and characterization process to avoid the generation of erroneous results.
引用
收藏
页码:307 / 316
页数:10
相关论文
共 19 条
  • [1] Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles
    Alyautdin, RN
    Petrov, VE
    Langer, K
    Berthold, A
    Kharkevich, DA
    Kreuter, J
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (03) : 325 - 328
  • [2] CALVO P, 2003, EUR J PHARM SCI, V20, P73
  • [3] Physical characterization and macrophage cell uptake of mannan-coated nanoparticles
    Cui, ZR
    Hsu, CH
    Mumper, RJ
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (06) : 689 - 700
  • [4] Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy
    De, SJ
    Robinson, DH
    [J]. AAPS PHARMSCITECH, 2004, 5 (04)
  • [5] DOWLING AP, 2004, NANO TODAY, V1, P30
  • [6] Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
    Fonseca, C
    Simoes, S
    Gaspar, R
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 83 (02) : 273 - 286
  • [7] Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer
    Lee, WK
    Park, JY
    Yang, EH
    Suh, H
    Kim, SH
    Chung, DS
    Choi, K
    Yang, CW
    Park, JS
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 84 (03) : 115 - 123
  • [8] PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution
    Mainardes, RM
    Evangelista, RC
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 290 (1-2) : 137 - 144
  • [9] MATTISON KW, 2004, AM BIOTECHNOL LAB, V12, P1
  • [10] Molpeceres J, 2000, J MICROENCAPSUL, V17, P599